Workflow
供应链
icon
Search documents
食品饮料行业周报:白酒压力释放,关注高景气品类
Donghai Securities· 2025-05-13 12:25
Investment Rating - The report assigns an "Overweight" rating for the food and beverage industry, indicating that the industry index is expected to outperform the CSI 300 index by 10% or more over the next six months [1]. Core Insights - The report highlights a positive outlook for the dairy sector driven by favorable policies related to fertility, which are expected to boost demand. The supply-demand balance for raw milk is anticipated to improve, leading to stabilization in milk prices [4]. - In the liquor segment, the focus is on high-end products and regional leaders, with specific recommendations for companies like Kweichow Moutai and Wuliangye. The report notes that the white liquor sector is currently experiencing a bottoming out in valuations, with expectations for demand recovery supported by policy measures [4]. - The snack food sector continues to show high growth potential, with recommendations for companies such as Yanjinpuzi and Ganyuan Food. The report also emphasizes the resilience of the restaurant supply chain, suggesting investments in companies like Anjifood and Qianwei Yangchun [4]. Summary by Sections 1. Market Performance - The food and beverage sector rose by 1.76% last week, underperforming the CSI 300 index by 0.24 percentage points, ranking 20th among 31 sectors [5][10]. - The best-performing sub-sectors included health products and baked goods, which increased by 5.09% and 4.25%, respectively [10]. 2. Key Consumption and Raw Material Prices - The report provides detailed pricing data for key liquor products, noting that the price of the 2024 Moutai original bottle is 2,190 yuan, reflecting a slight increase from the previous week [20]. - In the beer sector, production for March 2025 reached 312.8 million hectoliters, a year-on-year increase of 1.9% [25]. 3. Industry Dynamics - The report notes a 2% year-on-year decline in liquor prices as of April, with overall food and beverage prices showing a slight increase [55]. 4. Core Company Updates - Qingdao Beer plans to acquire 100% equity of Jimo Huangjiu from Xinhua Jin Group and Lujin Group for 666 million yuan [56]. - Baba Foods announced a cash dividend of 0.80 yuan per share, totaling 192 million yuan [56].
浙商中拓(000906) - 2025年5月13日投资者关系活动记录表
2025-05-13 12:14
| 投资者关系 | □特定对象调研 □分析师会议 | | --- | --- | | 活动类别 | □媒体采访 业绩说明会 | | | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 | | 参与单位名 | 以网络远程方式参与公司"2025 年浙江辖区上市公司投资者网上 | | 称及人员姓 | | | 名 | 集体接待日暨 2024 年度业绩说明会" | | 时间 | 2025 年 5 月 13 日 15:00 至 17:00 | | 地点 | 杭州 | | 上市公司接 | 董事长袁仁军先生、副董事长杨威先生、董事、总经理李文明先生、 | | 待人员姓名 | 独立董事许永斌先生、财务总监邓朱明先生、副总经理兼董事会秘 | | | 书雷邦景先生 | | | 1、问:1、请介绍一下江苏德龙欠公司货款问题解决的情况? | | | 公司有多大把握解决这些货款问题?2、介绍一下公司前 4 个月的 | | | 经营情况?3、大股东提出增持股份已一个月了,贷款也到手了, | | 投资者关系 | 到底开始增持股份了没有? | | 活动主要内 | 答:您好,诉讼进展情况公司将及时进行披露,请关注有关公 ...
东方嘉盛(002889) - 002889东方嘉盛投资者关系管理信息20250513
2025-05-13 11:44
证券代码:002889 证券简称:东方嘉盛 深圳市东方嘉盛供应链股份有限公司 投资者关系活动记录表 回答2:公司积极把握战略产业发展机遇,深化重点龙头客户 服务合作,为华南片区集成电路制造企业提供全天候快速响应的光 刻机保税寄售维修服务。公司将持续扩大客户基础,基于客户和市 场需要不断覆盖更加多元化精细化的供应链管理产品,配合深圳自 建仓库的建成打造半导体设备厂商保税寄售维修供应链行业标准, 为深圳打造半导体设备厂商良性的售后服务生态圈。同时公司也将 凭借领先的供应链资源统筹配置与战略投资孵化能力,积极探索半 导体产业链上下游业务延伸机会,发掘产业链中服务与贸易等环节 的增量潜能。 3.公司自建仓储项目进展如何?对公司业绩有什么帮助? 回答3:目前公司的重庆、昆明自建项目已竣工,深圳等地自 建仓储项目也正有序进行,建成后将重点服务跨境电商及半导体行 业。未来公司将积极推进自有仓库建设进程,通过提高自有仓库占 比以减少外部仓库租赁成本,提升公司业绩质量。同时,公司也将 进一步完善公司的全球仓储网络布局,在国内重点经济带推动与战 略型产业的合作机会,抓住新贸易格局下的行业成长红利。 4.公司去年业绩增长原因是什么 ...
上海票据交易所发布重要通知!涉及这些关键要点→
Jin Rong Shi Bao· 2025-05-13 03:30
Group 1 - The supply chain finance sector is experiencing growth in 2024, with an improved financing environment for small and medium-sized enterprises (SMEs) in China, despite traditional challenges such as fund occupation and accounts receivable delays [1] - The implementation of the "Notice on Regulating Supply Chain Finance Business" starting June 15, 2025, outlines 21 key tasks aimed at guiding the development of the industry, including the promotion of timely payments by core supply chain enterprises [2] - The Shanghai Commercial Paper Exchange has issued a notification detailing ten specific requirements for the reporting of accounts receivable electronic voucher business information, ensuring orderly progress in subsequent information reporting [2] Group 2 - The notification emphasizes that various financial institutions, including policy banks and foreign banks, must adhere to the reporting requirements for accounts receivable electronic voucher business information [3] - Reporting institutions are required to submit their accounts receivable electronic voucher business information directly to the Shanghai Commercial Paper Exchange and are prohibited from delegating this task to others [3] - Institutions and related parties must avoid making false or misleading claims regarding the reporting of accounts receivable electronic voucher business information to enterprises [3]
东方嘉盛(002889) - 002889东方嘉盛投资者关系管理信息20250512
2025-05-12 12:09
证券代码:002889 证券简称:东方嘉盛 深圳市东方嘉盛供应链股份有限公司 投资者关系活动记录表 编号:2025-002 投资者关系活动类别 特定对象调研 ☐分析师会议 ☐媒体采访 ☐业绩说明会 ☐新闻发布会 ☐路演活动 ☐现场参观 ☐其他(请文字说明其他活动内容) 参与单位名称及人员姓名 永赢基金 张海啸 国泰基金 林知 时间 2025年05月12日 15:00-17:00 地点 上海市浦东新区二十一世纪中心大厦 上海市虹口区嘉昱大厦 上市公司接待人员姓名 董事会秘书 李旭阳 投资者关系经理 肖文 投资者关系活动主要内容 介绍 1.国际形势缓和对公司的业务有什么影响? 回答1:国际形势缓和将减少行业波动因素,带动提振国际消 费与物流需求,长期来看将增强跨境供应链的稳定性,助力各行业 进出口业务的增长。此外,目前公司现已经加速全球供应链服务网 络布局,同步布局欧洲、中亚、中东及拉美等新兴市场,分散单一 市场风险,凭借跨境多式联运产品、全球供应链服务网络以及垂直 赛道的供应链体系建设,寻求更多市场及业务机会。同时,公司也 正积极引入AI模型以及数字化系统实时跟踪订单、库存及物流动 态,协同产业链上下游进行风险 ...
40万亿供应链金融市场迎新规 直击哪些行业潜规则?
Core Viewpoint - The new regulations on supply chain finance in China aim to enhance the protection of small and medium-sized enterprises (SMEs) and improve the overall health of the supply chain finance ecosystem, effective from June 15, 2025 [1][2]. Summary by Relevant Sections Regulatory Changes - The People's Bank of China, along with several regulatory bodies, has issued new guidelines that officially include accounts receivable electronic vouchers into the regulatory framework, which is expected to foster industry development and innovation [2][3]. - The new regulations signal a shift towards "de-financialization" of supply chain finance platforms, emphasizing their role as information platforms rather than credit platforms, which will promote healthier development of third-party platforms [2][3]. Risk Management - The new regulations introduce a comprehensive credit risk management system, including monitoring of all debts of core enterprises and addressing risks associated with bill circulation [3][4]. - The regulations replace the previous cash flow indicators with a focus on the financial condition of enterprises as a risk warning metric, aiming to create a more robust credit risk prevention framework [3][4]. Payment Practices - The regulations address the issue of delayed payments to SMEs by core enterprises, mandating timely payments and prohibiting unreasonable payment terms or the abuse of non-cash payment methods to extend payment periods [5][6]. - The maximum payment period for accounts receivable electronic vouchers is set at six months, with a maximum of one year [5][6]. Fee Structures - The new guidelines regulate the charging practices of core enterprises and supply chain information service providers, ensuring that fees related to accounts receivable confirmation are reasonable and transparent [6][7]. - Core enterprises are prohibited from charging SMEs under the guise of accounts receivable confirmation and must clearly define and publicize their service fee standards [6][7].
医药行业周报:关注血透、药房等细分领域投资机遇
Minsheng Securities· 2025-05-12 10:23
医药行业周报 关注血透、药房等细分领域投资机遇 2025 年 05 月 12 日 ➢ 医药周观点:医药设备招投标持续复苏,重点关注血透、超声等细分领域国产替 代机遇。此外,连锁药房领域内随着中小厂商的陆续出清,龙头厂商有望借助行业加 速整合机遇迎来市占率提升。 ➢ 1)创新药:云顶新耀布地奈德肠溶胶囊获得 NMPA 完全批准,翰森制药阿美 替尼辅助适应症获批上市,建议关注国内外研发进展。2)CXO:国内需求逐步回暖, 海外需求平稳向上,且目前对关税政策免疫,看好板块龙头企业逐季度订单和报表的 持续兑现带来的估值修复,重点关注药明生物、药明康德、凯莱英和康龙化成。3) 中医药:中医药方面,后续建议关注与生育补贴息息相关的标的,例如具备儿科用药 布局的济川药业、葵花药业等。4)疫苗及血制品:持续看好静丙行业未来 3-5 年的 发展潜力,其次关注浆站数量变化及头部集中背景下吨浆利润提升驱动的行业上行周 期中潜在受益的龙头公司,重视重组人白的获批进程以及潜在的产业变革。疫苗方向 基本面整体承压但部分重点公司业绩边际改善,关注重点公司 24 年下游库存周期改 善带来的业绩拐点及 mcv4 疫苗 25 年市场拓展情况。5 ...
医药行业周报:关注血透、药房等细分领域投资机遇-20250512
Minsheng Securities· 2025-05-12 09:51
医药行业周报 关注血透、药房等细分领域投资机遇 2025 年 05 月 12 日 ➢ 医药周观点:医药设备招投标持续复苏,重点关注血透、超声等细分领域国产替 代机遇。此外,连锁药房领域内随着中小厂商的陆续出清,龙头厂商有望借助行业加 速整合机遇迎来市占率提升。 ➢ 1)创新药:云顶新耀布地奈德肠溶胶囊获得 NMPA 完全批准,翰森制药阿美 替尼辅助适应症获批上市,建议关注国内外研发进展。2)CXO:国内需求逐步回暖, 海外需求平稳向上,且目前对关税政策免疫,看好板块龙头企业逐季度订单和报表的 持续兑现带来的估值修复,重点关注药明生物、药明康德、凯莱英和康龙化成。3) 中医药:中医药方面,后续建议关注与生育补贴息息相关的标的,例如具备儿科用药 布局的济川药业、葵花药业等。4)疫苗及血制品:持续看好静丙行业未来 3-5 年的 发展潜力,其次关注浆站数量变化及头部集中背景下吨浆利润提升驱动的行业上行周 期中潜在受益的龙头公司,重视重组人白的获批进程以及潜在的产业变革。疫苗方向 基本面整体承压但部分重点公司业绩边际改善,关注重点公司 24 年下游库存周期改 善带来的业绩拐点及 mcv4 疫苗 25 年市场拓展情况。5 ...
交运24年度复盘及25Q1总结:交运整体稳健,看好物流发展
Xinda Securities· 2025-05-11 05:23
交运整体稳健,看好物流发展 [Table_Industry] 交运 24 年度复盘及 25Q1 总结 [Table_ReportDate] 2025 年 5 月 9 日 证券研究报告 行业研究 [Table_ReportType] 行业专题研究(深度) | [Table_StockAndRank] 交通运输 | | | --- | --- | | 投资评级 | 看好 | | 上次评级 | 看好 | [Table_Author] 匡培钦 交运行业首席分析师 执业编号:S1500524070004 邮 箱:kuangpeiqin@cindasc.com 黄安 交运行业分析师 秦梦鸽 交运行业分析师 陈依晗 交运行业研究助理 邮 箱:chenyihan@cindasc.com 信达证券股份有限公司 CINDA SECURITIES CO.,LTD 北京市西城区宣武门西大街甲127号金隅大厦 B座 邮编:100031 [Table_Title] 交运 24 年度复盘及 25Q1 总结:交运整体稳 健,看好物流发展 [Table_ReportDate] 2025 年 5 月 9 日 [Table_S [➢Table_S ...
大成研究 | 马宏伟等:证券合规地图系列文章(十八):供应链金融环节中的上市公司合规风险
Sou Hu Cai Jing· 2025-05-11 01:31
Group 1 - The core viewpoint of the article emphasizes the importance of regulatory measures to prevent risks and promote high-quality development in the capital market, as outlined in the new "National Nine Articles" [2] - The article discusses the need for a comprehensive approach to address compliance risks faced by listed companies, focusing on operational compliance, duty compliance, service compliance, and regulatory procedures [2] - The article is part of a series aimed at creating a compliance map for listed companies, specifically addressing operational compliance [2] Group 2 - Supply chain finance is defined as a financial innovation that integrates the flow of funds, goods, and information along the supply chain, aimed at alleviating financing pressure on small and medium-sized enterprises while enhancing overall operational efficiency [3][4] - The development of supply chain finance is currently in a strengthening phase, with significant policy support aimed at achieving comprehensive financial service coverage for key enterprises by the end of 2025 [5] - The article outlines three main models of supply chain finance: seller financing, buyer financing, and their respective sub-models [6][7][9] Group 3 - Supply chain finance presents risks for listed companies, particularly external risks such as legal and credit risks, which can arise from fraudulent activities or the creditworthiness of upstream and downstream enterprises [10][12] - Internal risks include operational and compliance risks, where companies must ensure strict internal controls to avoid becoming complicit in fraudulent activities [14][15] - The article provides examples of past incidents where companies faced significant legal and financial repercussions due to failures in managing supply chain finance risks [11][13] Group 4 - To mitigate risks associated with supply chain finance, listed companies should enhance external risk prevention measures, including credit assessments of involved enterprises and monitoring of logistics and warehousing [16] - Establishing internal risk response mechanisms is crucial, emphasizing the need for a strong compliance culture and adherence to regulatory trends to avoid potential legal issues [18]